Is a complete CRBU research report available?

No complete published report is available for Caribou Biosciences, Inc. (CRBU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · USD

$0.49

+0.03 (+5.5%)· Recorded snapshot

Market cap	52.1M
Revenue (ttm)	10M
Net income (ttm)	-103.4M
EPS (ttm)	-$1.08
Shares out	107.2M
Volume	926,437
Beta	2.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10M
Net income (ttm): -103.4M
EPS (ttm): -$1.08
Market cap: 52.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001619856
Company name	Caribou Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	142038108
Earnings date	2026-11-11
Earnings time	amc
Employees	97
Employees change	-50
Employees growth	-34.01%
Enterprise value	$-35M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2021-07-23
Is primary listing	Yes
Is SPAC	No
ISIN number	US1420381089
Last 10-K release date	2026-03-05
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$52.1M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	Yes
Price	$0.49
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CRBU
U.S. state	California
Website	https://cariboubio.com

Metric

Value

Amount currency

USD

CIK code

0001619856

Company name

Caribou Biosciences, Inc.

Country

United States

Country code

CUSIP number

142038108

Earnings date

2026-11-11

Earnings time

amc

Employees

Employees change

-50

Employees growth

-34.01%

Enterprise value

$-35M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2011

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2021-07-23

Is primary listing

Yes

Is SPAC

ISIN number

US1420381089

Last 10-K release date

2026-03-05

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$52.1M

Market cap category

Micro-Cap

Next earnings date

2026-11-11

Options

Yes

Price

$0.49

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CRBU

U.S. state

California

Website

https://cariboubio.com

Metric	Value
Earnings yield	-221.12%
FCF / EV yield	265.16%
FCF yield	-187.56%
Forward P/S	2.18x
P/B ratio	0.5x
P/S ratio	5.09x
Price / tangible book value	0.52x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-221.12%

FCF / EV yield

265.16%

FCF yield

-187.56%

Forward P/S

2.18x

P/B ratio

0.5x

P/S ratio

5.09x

Price / tangible book value

0.52x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Operating margin	-1,068.22%
Pretax margin	-1,035.9%
Profit per employee	$-1.1M
Revenue per employee	$103,454
ROA	-36.84%
ROA (5Y)	-22.8%
ROCE	-85.89%
ROE	-78.27%
ROE (5Y)	-43.87%
ROIC	-42.3%
SBC / revenue	104.66%
Tax / revenue	-5.48%

Metric

Value

Operating margin

-1,068.22%

Pretax margin

-1,035.9%

Profit per employee

$-1.1M

Revenue per employee

$103,454

ROA

-36.84%

ROA (5Y)

-22.8%

ROCE

-85.89%

ROE

-78.27%

ROE (5Y)

-43.87%

ROIC

-42.3%

SBC / revenue

104.66%

Tax / revenue

-5.48%

Metric	Value
EPS growth quarters	4
EPS growth years	1
Net income growth quarters	4
Net income growth years	1
Revenue growth	10.02%
Revenue growth (Q)	-43.8%
Revenue growth (QoQ)	-37.46%
Revenue growth 3Y	-11.04%
Revenue growth 5Y	13.86%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

10.02%

Revenue growth (Q)

-43.8%

Revenue growth (QoQ)

-37.46%

Revenue growth 3Y

-11.04%

Revenue growth 5Y

13.86%

Revenue growth years

Metric	Value
Capital expenditures	$28,000
Depreciation and amortization	$2.6M
EBIT	$-107.2M
EBITDA	$-104.6M
EPS	$-1.08
FCF per share	$-0.89
Financing cash flow	$25M
Free cash flow	$-95.8M
Free cash flow minus SBC	$-106.3M
Gross profit	$-73.8M
Income taxes	$-550,000
Investing cash flow	$71.7M
Net cash flow	$947,000
Net income	$-103.4M
Operating cash flow minus SBC	$-106.3M
Operating income	$-107.2M
Revenue	$10M
Stock-based compensation	$10.5M

Metric

Value

Capital expenditures

$28,000

Depreciation and amortization

$2.6M

EBIT

$-107.2M

EBITDA

$-104.6M

EPS

$-1.08

FCF per share

$-0.89

Financing cash flow

$25M

Free cash flow

$-95.8M

Free cash flow minus SBC

$-106.3M

Gross profit

$-73.8M

Income taxes

$-550,000

Investing cash flow

$71.7M

Net cash flow

$947,000

Net income

$-103.4M

Operating cash flow minus SBC

$-106.3M

Operating income

$-107.2M

Revenue

$10M

Stock-based compensation

$10.5M

Metric	Value
Altman Z-Score	-5.47
Book value per share	$0.93
Debt / equity	0.27
Long-term assets	$26.2M
Long-term liabilities	$26.7M
Net cash (debt)	$87.2M
Net cash / market cap	170.73%
Net cash growth	-44.87%
Net debt / equity	-0.89
Piotroski F-Score	3
Property, plant and equipment	$22.5M
Shareholders' equity	$98.1M
Tangible book value	$98.1M
Tangible book value per share	$0.93
Total assets	$142.8M
Total cash	$112.3M
Total debt	$26.7M
Total liabilities	$44.7M
WACC	11.14%

Metric

Value

Altman Z-Score

-5.47

Book value per share

$0.93

Debt / equity

0.27

Long-term assets

$26.2M

Long-term liabilities

$26.7M

Net cash (debt)

$87.2M

Net cash / market cap

170.73%

Net cash growth

-44.87%

Net debt / equity

-0.89

Piotroski F-Score

Property, plant and equipment

$22.5M

Shareholders' equity

$98.1M

Tangible book value

$98.1M

Tangible book value per share

$0.93

Total assets

$142.8M

Total cash

$112.3M

Total debt

$26.7M

Total liabilities

$44.7M

WACC

11.14%

Metric	Value
Asset turnover	0.06
Current assets	$116.6M
Current liabilities	$18M
Current ratio	6.49
Net working capital	$-12.3M
Quick ratio	6.36
Working capital	$98.6M
Working capital turnover	0.08

Metric

Value

Asset turnover

0.06

Current assets

$116.6M

Current liabilities

$18M

Current ratio

6.49

Net working capital

$-12.3M

Quick ratio

6.36

Working capital

$98.6M

Working capital turnover

0.08

Metric	Value
Buyback yield / dilution	-4.73%
Dividend yield	0%
Shareholder yield	-4.73%

Metric

Value

Buyback yield / dilution

-4.73%

Dividend yield

Shareholder yield

-4.73%

Metric	Value
150-day SMA	$1.62
1D price change	5.54%
1M price change	-61.7%
1M total return	-61.7%
1W price change	-8.49%
1W total return	-8.49%
1Y price change	-80.61%
1Y return CAGR	-80.64%
1Y total return	-80.61%
20-day SMA	$0.64
200-day SMA	$1.64
3M price change	-70.13%
3M total return	-70.13%
3Y price change	-87.02%
3Y return CAGR	-49.36%
3Y total return	-87.02%
50-day SMA	$1.12
50-day SMA vs 200-day SMA	50under200
52-week high	$3.54
52-week high date	2025-11-03
52-week low	$0.44
52-week low date	2026-10-09
5Y price change	-97.92%
5Y return CAGR	-53.9%
5Y total return	-97.92%
6M price change	-77.7%
6M total return	-77.7%
All-time high	$32.65
All-time high date	2021-09-07
All-time low	$0.44
All-time low date	2026-10-09
Average true range (ATR)	$0.06
Average volume	5.7M
Beta (1Y)	2.12
Beta (2Y)	2.16
Beta (5Y)	2.31
Change from 52-week high	-86.25%
Change from 52-week low	9.88%
Change from all-time high	-98.55%
Change from all-time low	7.33%
Change from open	3.36%
Day's gap	2.11%
Dollar volume	$450,434
High price	$0.49
Low price	$0.46
Monthly RSI	35.46
Open price	$0.47
Position in 52-week range	100%
Premarket change	4.19%
Premarket close	$0.46
Premarket price	$0.48
Premarket volume	4.4K
Previous close	$0.46
Price vs 150-day SMA	-70.63%
Price vs 20-day SMA	-25.4%
Price vs 200-day SMA	-71.07%
Price vs 50-day SMA	-57.59%
Relative volume	0.16
Return from IPO open	-97.3%
Return from IPO price	-97.02%
RSI	24.13
Sharpe ratio	-1.54
Sharpe ratio (3Y)	-0.38
Sharpe ratio (5Y)	-0.46
Sortino ratio	-1.77
Sortino ratio (3Y)	-0.46
Sortino ratio (5Y)	-0.59
Volume	926.4K
Weekly RSI	27.66
YTD price change	-70.13%
YTD total return	-70.13%

Metric

Value

150-day SMA

$1.62

1D price change

5.54%

1M price change

-61.7%

1M total return

-61.7%

1W price change

-8.49%

1W total return

-8.49%

1Y price change

-80.61%

1Y return CAGR

-80.64%

1Y total return

-80.61%

20-day SMA

$0.64

200-day SMA

$1.64

3M price change

-70.13%

3M total return

-70.13%

3Y price change

-87.02%

3Y return CAGR

-49.36%

3Y total return

-87.02%

50-day SMA

$1.12

50-day SMA vs 200-day SMA

50under200

52-week high

$3.54

52-week high date

2025-11-03

52-week low

$0.44

52-week low date

2026-10-09

5Y price change

-97.92%

5Y return CAGR

-53.9%

5Y total return

-97.92%

6M price change

-77.7%

6M total return

-77.7%

All-time high

$32.65

All-time high date

2021-09-07

All-time low

$0.44

All-time low date

2026-10-09

Average true range (ATR)

$0.06

Average volume

5.7M

Beta (1Y)

2.12

Beta (2Y)

2.16

Beta (5Y)

2.31

Change from 52-week high

-86.25%

Change from 52-week low

9.88%

Change from all-time high

-98.55%

Change from all-time low

7.33%

Change from open

3.36%

Day's gap

2.11%

Dollar volume

$450,434

High price

$0.49

Low price

$0.46

Monthly RSI

35.46

Open price

$0.47

Position in 52-week range

100%

Premarket change

4.19%

Premarket close

$0.46

Premarket price

$0.48

Premarket volume

4.4K

Previous close

$0.46

Price vs 150-day SMA

-70.63%

Price vs 20-day SMA

-25.4%

Price vs 200-day SMA

-71.07%

Price vs 50-day SMA

-57.59%

Relative volume

0.16

Return from IPO open

-97.3%

Return from IPO price

-97.02%

RSI

24.13

Sharpe ratio

-1.54

Sharpe ratio (3Y)

-0.38

Sharpe ratio (5Y)

-0.46

Sortino ratio

-1.77

Sortino ratio (3Y)

-0.46

Sortino ratio (5Y)

-0.59

Volume

926.4K

Weekly RSI

27.66

YTD price change

-70.13%

YTD total return

-70.13%

Metric	Value
Float	102.9M
Float percentage	95.99%
Shares change (QoQ)	5.35%
Shares change (YoY)	4.73%
Shares held by insiders	4.01%
Shares held by institutions	49.33%
Shares outstanding	107.2M
Short % of float	12.55%
Short % of shares	12.05%
Short ratio	11.1 days

Metric

Value

Float

102.9M

Float percentage

95.99%

Shares change (QoQ)

5.35%

Shares change (YoY)

4.73%

Shares held by insiders

4.01%

Shares held by institutions

49.33%

Shares outstanding

107.2M

Short % of float

12.55%

Short % of shares

12.05%

Short ratio

11.1 days

Caribou Biosciences, Inc. (CRBU)

Price

Financial snapshot

Fair-value bridge

Latest news · CRBU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CRBU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CRBU

Frequently asked questions